These Holley who told reporters. Yesterday,michael kors outlet online, Yunnan SASAC is not on the "First Financial Daily" position on the matter. In fact, the industry entered the Kunming Pharmaceutical Holley has been disputed. Especially in 2005, Kunming Pharmaceutical reported losses for the first time after 44.57 million yuan, which makes the Holley being questioned in Yunnan continues to heat up, did not think it would integrate well Kunming Pharmaceutical artemisinin resources. Meanwhile, on the issue of acquisition of Kunming Pharmaceutical, Holley also suffered a controversy.
Thus,Michael Kors outlet, pharmaceutical companies together hold 100% equity interest in Kunming. However, this acquisition lasted three long years in the pharmaceutical industry rumors are encountered boycott and delays for property transfer procedures. Because artemisinin resources belong to Kunming Pharmaceutical quality assets, from that point on, Holley will not easily give up this resource. And now, the results have been out of the Kunming Pharmaceutical losses fundamentals turnaround, the report in 2007 showed a net profit of 29.06 million yuan last year, an increase of 988.
Net profit in the first quarter nike air max shoes of this year, compared with 5.624 million yuan, an increase of 48. Michael Kors bags Performance is rising, the situation is good. Cheng Jun, vice president of the Kunming Pharmaceutical Group, told reporters. But this situation does not seem to change the Yunnan SASAC attempt to recover the idea of a controlling stake in Holley. The source told reporters in Kunming Pharmaceutical control over the change process, the second largest shareholder of Hongta Group mentality has been cause for concern. Holley eventually lost control of the Queensland drug, perhaps it will be Hongta Group.
Topics related articles：
No comments:
Post a Comment